Centaurus Biopharma Co., Ltd.
Records under this name other than the patents Centaurus Biopharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Back to Centaurus Biopharma Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,231,973 | Salts of Quinazoline Derivative and Method for Preparing the Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,561,657 | Pyrrolopyrimidine compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,617,692 | Pyrrolopyrimidine comprising cyclopentyl substituent Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,626,118 | Pyrrolopyrimidine crystal for preparing JAK inhibitor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,766,901 | Preparation method for chiral pyrrolopyrimidine compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,098,060 | Macrocycle Containing Aminopyrazole and Pyrimidine and Pharmaceutical Composition and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,772,312 | Heterocyclic Compounds as CRTH2 Receptor Antagonists Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 10,858,340 | Crystal of salt of quinazoline derivative Lapsed on the fee record Ended Dec 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2024 | From the USPTO record |
| US 10,450,328 | Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |
| US 10,155,775 | Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors Lapsed on the fee record Ended Dec 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2022 | From the USPTO record |